Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Junjie Chen
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2000
Papers
237
H Index
83
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37577639
DePARylation is critical for S phase progression and cell survival.
bioRxiv
2024
36336962
Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis.
Cancer Commun (Lond)
2023
37612613
Ultrasound-Targeted Microbubble Destruction Assisted Delivery of Platelet-Rich Plasma-Derived Exosomes Promoting Peripheral Nerve Regeneration.
Tissue Eng Part A
2023
37541219
FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways.
Mol Cell
2023
37540752
Multiomics analyses reveal <i>DARS1-AS1</i>/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.
Sci Adv
2023
37606102
A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
Eur Rev Med Pharmacol Sci
2023
37047518
Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway.
Int J Mol Sci
2023
37133119
Drift correction in laboratory nanocomputed tomography using joint feature correlation.
Appl Opt
2023
36747082
Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Nat Cell Biol
2023
36743158
Relationship between self-care compliance, trust, and satisfaction among hypertensive patients in China.
Front Public Health
2023
35885192
Multiscale Dense U-Net: A Fast Correction Method for Thermal Drift Artifacts in Laboratory NanoCT Scans of Semi-Conductor Chips.
Entropy (Basel)
2022
35771632
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.
Cancer Res
2022
35704761
Integrated screens uncover a cell surface tumor suppressor gene <i>KIRREL</i> involved in Hippo pathway.
Proc Natl Acad Sci U S A
2022
35687697
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Sci Immunol
2022
35559673
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.
Sci Adv
2022
35936365
Evaluation of the Effect of Integrated Care on Preoperative Anxiety in Day Surgery Patients Based on the MVPA Framework.
Comput Math Methods Med
2022
35869071
TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Nat Commun
2022
36302555
USP7 substrates identified by proteomics analysis reveal the specificity of USP7.
Genes Dev
2022
33289385
Selective Labeling and Identification of the Tumor Cell Proteome of Pancreatic Cancer <i>In Vivo</i>.
J Proteome Res
2021
33626321
PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.
Mol Cell
2021
33707434
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation.
Nat Commun
2021
34626540
Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation.
Dev Cell
2021
34188037
Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance.
Nat Commun
2021
34320214
Genetic vulnerabilities upon inhibition of DNA damage response.
Nucleic Acids Res
2021
34232536
Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
EMBO J
2021
34197614
Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2.
Nucleic Acids Res
2021
32314919
Phosphoproteomics Analysis Reveals a Potential Role of CHK1 in Regulation of Innate Immunity through IRF3.
J Proteome Res
2020
31995761
The ARK Assay Is a Sensitive and Versatile Method for the Global Detection of DNA-Protein Crosslinks.
Cell Rep
2020
31900314
AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair.
Mol Cell Proteomics
2020
31782549
Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.
EMBO J
2020
31991288
CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions.
DNA Repair (Amst)
2020
31921408
DNA-protein cross-link repair: what do we know now?
Cell Biosci
2020
33376220
DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress.
Proc Natl Acad Sci U S A
2020
33338401
A Surge of DNA Damage Links Transcriptional Reprogramming and Hematopoietic Deficit in Fanconi Anemia.
Mol Cell
2020
32853826
C17orf53 is identified as a novel gene involved in inter-strand crosslink repair.
DNA Repair (Amst)
2020
32989218
Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation.
Oncogenesis
2020
32958691
Proteome-wide Analysis Reveals Substrates of E3 Ligase RNF146 Targeted for Degradation.
Mol Cell Proteomics
2020
32783940
FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function.
Cell Rep
2020
32307824
HMCES safeguards replication from oxidative stress and ensures error-free repair.
EMBO Rep
2020
32300176
Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition.
Oncogene
2020
32484965
ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.
EMBO J
2020
30532030
Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition.
Oncogene
2019
31554794
Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
Nat Commun
2019
31495888
SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.
Nucleic Acids Res
2019
31633027
Nuclear receptors regulate alternative lengthening of telomeres through a novel noncanonical FANCD2 pathway.
Sci Adv
2019
31067464
Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2.
Cell Rep
2019
30631047
Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics.
Nat Commun
2019
29669287
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.
Cell Rep
2018
30181621
Author Correction: Topoisomerase IIα controls the decatenation checkpoint.
Nat Cell Biol
2018
30202049
BAP1 links metabolic regulation of ferroptosis to tumour suppression.
Nat Cell Biol
2018
1 - 50 of 237
Column Actions
Search
Recommended Authors
Marc Wiedner
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2013
Number of shared co-authors
0
Sichun Lin
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year
2012
Number of shared co-authors
1
Samah El Ghamrasni
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2010
Number of shared co-authors
1
Srikanth Talluri
VA Boston Healthcare System
Career Start Year
2008
Number of shared co-authors
1
Georgia Velimezi
University of Patras
Career Start Year
2008
Number of shared co-authors
0
Bingbing Wan
Shanghai Jiao Tong University
Career Start Year
2007
Number of shared co-authors
0
Laura Pontano Vaites
Harvard Medical School
Career Start Year
2007
Number of shared co-authors
0
Andreas Mund
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year
2006
Number of shared co-authors
1
Kizhakke M Sathyan
Center for Cell Analysis and Modeling, University of Connecticut
Career Start Year
2005
Number of shared co-authors
0
Ga??lle Legube
CNRS, Universite de Toulouse
Career Start Year
2002
Number of shared co-authors
1
Joanna I Loizou
Center for Cancer Research, Comprehensive Cancer Centre, Medical University of Vienna
Career Start Year
2002
Number of shared co-authors
1
Kyle M Miller
The University of Texas at Austin
Career Start Year
2001
Number of shared co-authors
1
Haico van Attikum
Leiden University Medical Center
Career Start Year
2001
Number of shared co-authors
3
Tarek Abbas
University of Virginia
Career Start Year
2001
Number of shared co-authors
0
Claudia Lukas
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year
1999
Number of shared co-authors
0
Dipanjan Chowdhury
Dana-Farber Cancer Institute
Career Start Year
1999
Number of shared co-authors
3
Thomas Helleday
The University of Sheffield
Career Start Year
1998
Number of shared co-authors
1
Aaron Aslanian
Salk Institute for Biological Studies
Career Start Year
1998
Number of shared co-authors
0
Marcus B Smolka
Weill Institute for Cell and Molecular Biology, Cornell University
Career Start Year
1998
Number of shared co-authors
0
Agata Smogorzewska
Instituto de Investigacion Sanitaria Hospital 12 de Octubre (imas12)
Career Start Year
1997
Number of shared co-authors
1
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
11
Daniel Durocher
The Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1995
Number of shared co-authors
4
Christopher J Bakkenist
UPMC Hillman Cancer Center, University of Pittsburgh
Career Start Year
1994
Number of shared co-authors
1
David P Toczyski
University of California San Francisco
Career Start Year
1991
Number of shared co-authors
0
Alex Vassilev
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Stephen P Jackson
Mission Therapeutics Ltd. Glenn Berge Building
Career Start Year
1987
Number of shared co-authors
4
Razqallah Hakem
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1987
Number of shared co-authors
1
Ashok R Venkitaraman
University of Cambridge, Hutchison Research Centre
Career Start Year
1982
Number of shared co-authors
1
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
3
Alan D D'Andrea
Dana-Farber Cancer Institute
Career Start Year
1978
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Wenyi Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
33
Traver Hart
University of Texas MD Anderson Cancer Center
Co-authored papers
11
Jun Qin
Co-authored papers
7
Mien-Chie Hung
Co-authored papers
7
Min Gao
College of Horticulture, China Agricultural University
Co-authored papers
6
Sung Yun Jung
Co-authored papers
5
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers
4
Zhongming Zhao
Center for Precision Health, The University of Texas Health Science Center at Houston
Co-authored papers
4
Han Liang
MD Anderson Cancer Center
Co-authored papers
4
Tanya T Paull
University of Texas at Austin
Co-authored papers
4
Daniel D Billadeau
Co-authored papers
2
Vicente Planelles
University of Utah
Co-authored papers
2
Antrix Jain
Co-authored papers
2
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Scott H Kaufmann
Mayo Clinic
Co-authored papers
2
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Shu Zhang
The Second Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers
2
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
1
Vivek Shukla
Chalmers University of Technology
Co-authored papers
1
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Nora M Navone
MD Anderson Cancer Center
Co-authored papers
1
Wanding Zhou
University of Pennsylvania
Co-authored papers
1
Kai Ge
Co-authored papers
1
Jia Fei
Co-authored papers
1
Vitold E Galkin
Eastern Virginia Medical School
Co-authored papers
1
Xian Fan
Rice University
Co-authored papers
1
Hae-Yun Jung
College of Life Science, CHA University
Co-authored papers
1
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Co-authored papers
1
Thomas Ried
Center for Cancer Research, National Cancer Institute
Co-authored papers
1
Edward H Egelman
University of Virginia
Co-authored papers
1
1 - 30